Actively Recruiting
Temporal Interference Methods for Addiction Treatment
Led by Indiana University · Updated on 2026-02-10
120
Participants Needed
1
Research Sites
57 weeks
Total Duration
On this page
Sponsors
I
Indiana University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical study is testing whether a new non-invasive brain stimulation method, called temporal interference (TI), can reduce nicotine cravings and usage in people who vape. TI delivers mild electrical currents to the scalp in a way that targets deep brain areas involved in addiction, without the need for surgery. In this randomized controlled trial, participants will be assigned to one of three groups: TI stimulation to the nucleus accumbens, TI stimulation to the anterior insula, or a placebo (sham) condition. Each participant will attend a single stimulation session after 8 hours of nicotine abstinence and will use a custom vape device that measures real-time nicotine inhalation. Craving levels will be reported during and after the session. The study aims to determine whether TI to the insula or nucleus accumbens is more effective at decreasing cravings and nicotine inhalation, and whether either is more effective than sham stimulation. For one week after the session, participants will use a smartphone app to track nicotine use and cravings. The primary hypothesis is that TI stimulation to deep brain regions will reduce both nicotine craving and actual use, immediately after stimulation and over the following week, compared to the sham condition.
CONDITIONS
Official Title
Temporal Interference Methods for Addiction Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between the ages of 21 and 50
- Nicotine dependent and vape at least 15 mg nicotine per day
- Must have a phone with internet access
- At least a 6th grade education and able to speak and read English
You will not qualify if you...
- History of seizures, seizure disorders, or family history of seizure disorders
- History of intractable migraine or complicated migraine syndromes
- History of suicide attempts or active suicidal thoughts in the past month
- History of cardiac arrhythmias, prolonged QT, pacemakers, or cardiovascular disorders
- Hypertension with systolic blood pressure over 150 mmHg
- Central nervous system structural lesions such as tumors, multiple sclerosis, or strokes
- Active neuropsychiatric disorders including schizophrenia, bipolar disorder, active psychosis, or dementia
- History of head trauma with loss of consciousness, skull fractures, or subdural hematomas
- Active use of opioids, cocaine, or methamphetamine
- Active severe cannabis use disorder
- Active alcohol use disorder or history of alcohol withdrawal
- Metal implants in the head or under the scalp (excluding dental implants)
- Current smoking cessation treatment or medications affecting reward processing
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Indiana University
Bloomington, Indiana, United States, 47403
Actively Recruiting
Research Team
J
Joshua Brown, PhD
CONTACT
K
Kendall Moore, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here